OEM/ODM
Contact Us
Tel: +86-537-6728868
E-Mail: chairman@sdrxsw.com
WhatsApp/Wetchat: +86 13562721377
Add: No.8 Wucun Industrial Park, Qufu,Shandong,China. 273100
Product Description
Why Tablet Form Matters for Milk Thistle
Before discussing formulation, it's worth asking why tablets at all — when most milk thistle products on the market come in capsules.
Tablets offer three advantages that capsules cannot match for high-dose silymarin products:
Higher active ingredient load per unit. A standard milk thistle capsule holds 250-500mg of fill. A tablet can deliver 500-1500mg of active ingredients in a single unit. For brands positioning milk thistle as a high-potency liver support product — targeting doses of 420-600mg silymarin per serving — tablets achieve the target dose in 1 tablet instead of 2-3 capsules.
Better stability for oxidation-sensitive compounds. Silymarin's flavonolignans degrade when exposed to moisture, light, and oxygen. Tablets, with their compressed matrix and optional film coating, create a physical barrier that slows oxidation. Our stability data shows properly formulated milk thistle tablets retain >95% silymarin content at 24 months under accelerated conditions (40°C/75% RH), compared to 85-90% retention in standard hard capsules under the same conditions.
Lower unit cost at scale. For high-volume SKUs, tablet compression costs 30-40% less per unit than capsule filling, directly improving margin for brands competing in the mid-price segment.
The trade-off? Tablet manufacturing introduces compression-related challenges that capsule filling does not. This is where most contract manufacturers get it wrong.
The Real Challenge: Silymarin Dissolution in Tablet Form
Here's the data that should concern every brand owner sourcing milk thistle tablets:
Silybin — the primary and most active flavonolignan in silymarin — has an absolute oral bioavailability of approximately 0.45% (PMC12736914). Its aqueous solubility is only 50-430 μg/mL. Under simulated gastric conditions (pH 1.2), more than 20% of silybin degrades within 2 hours. And silybin is actively transported out of intestinal cells by P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) efflux pumps, further reducing absorption.
For a tablet product, this means the silymarin must first dissolve out of the compressed tablet matrix before it can even begin the already-difficult process of intestinal absorption. If the tablet doesn't disintegrate and dissolve properly in the gastrointestinal tract, the silymarin passes through undissolved — and the consumer gets zero benefit regardless of what the label claims.
A 2024 study (PMC10052194) analyzed commercial milk thistle supplements and found "alarming discrepancies between declared and detected chemical content" — with many products containing significantly less silymarin than stated on the label. Some products had no detectable silymarin at all.
This is the gap we engineer against.
How We Solve the Dissolution Problem
Our milk thistle tablet formulation follows a three-stage approach to ensure maximum silymarin release from every tablet:
Stage 1: Raw Material Standardization
We use milk thistle extract standardized to 80% total silymarin (UV method), with verified flavonolignan profile:
Flavonolignan | Typical Content (% of total silymarin) |
Silybin A + Silybin B | 40-65% |
Silychristin | 8-15% |
Silydianin | 2-6% |
Isosilybin A + Isosilybin B | 10-20% |
Taxifolin | 1-3% |
We verify the silybin B/silybin A ratio (typically ~1.58) and the (silybin B + isosilybin B)/(silybin A + isosilybin A) ratio (typically ~1.28) as authenticity markers, consistent with findings from compositional ratio analysis studies (PMC11243550). These ratios serve as fingerprint indicators — deviations signal adulteration or low-quality extract.
Stage 2: Dissolution-Enhanced Formulation
We don't simply compress raw silymarin extract into a tablet. Instead, we apply formulation strategies proven to enhance silymarin dissolution:
Solid dispersion technology. Dispersing silymarin in hydrophilic polymer matrices (such as PVP or HPMC) breaks the crystalline structure and creates an amorphous system with dramatically improved dissolution rate. Published research shows solid dispersions can achieve 5-fold improvement in oral bioavailability (PMC12736914).
Particle size reduction. Silymarin nanocrystal formulations have demonstrated 1.51-fold higher oral bioavailability in human pharmacokinetic studies (PMC11359960), with stable performance over 24 months. We control particle size distribution of the silymarin extract to optimize surface area for dissolution.
pH-modified microenvironment. Because silybin degrades at gastric pH (acidic) but dissolves better at neutral-to-alkaline pH, we can incorporate pH-modifying excipients that create a favorable local microenvironment around each dissolving particle — protecting silybin during the critical gastric phase.
Phytosome complex option. For premium product lines, we offer silymarin-phosphatidylcholine complex (phytosome) tablets. Clinical crossover studies show silybin-phosphatidylcholine complex achieves peak plasma concentrations of 207.1 ng/L compared to 12.6 ng/L for standard silymarin tablets — a 16.4-fold increase (PMC6330464).
Stage 3: Compression Process Control
Tablet compression generates heat and mechanical stress that can degrade silymarin if not properly controlled. Our process parameters:
- Compression force optimization: Balanced to achieve tablet hardness of 4-8 kp (sufficient for handling and packaging, low enough to avoid densification that blocks dissolution)
- Temperature monitoring: Compression zone kept below 40°C to prevent thermal degradation of flavonolignans
- Moisture control: Granulation moisture content maintained at 2-4% (excess moisture accelerates silymarin oxidation during storage)
- Low-shear blending: Short mixing times with silymarin extract to prevent heat buildup from friction
Product Specifications
Parameter | Details |
Active Ingredient | Milk Thistle Extract (Silybum marianum), standardized to 80% total silymarin |
Silymarin per Tablet | 150mg / 250mg / 300mg / 500mg (customizable) |
Tablet Weight | 500mg - 1500mg |
Tablet Shape | Round / Oval / Oblong / Capsule-shaped |
Tablet Type | Uncoated / Film-coated / Enteric-coated |
Disintegration Time | < 30 minutes (USP compliant) |
Shelf Life | 24-36 months (in sealed, light-resistant container) |
Certifications | ISO9001, ISO22000, FSSC22000, GMP, FDA-registered, HALAL, SC, REACH, ECOCERT |
Annual Capacity | 20 billion tablets (tablet + capsule combined line) |
Customization Options
Silymarin Strength: 150mg to 500mg per tablet, with or without synergistic co-ingredients (turmeric curcumin, NAC, artichoke extract, dandelion root, TUDCA)
Release Profile:
- Immediate release (standard): disintegration < 15 minutes
- Sustained release: controlled silymarin release over 8-12 hours via microporous osmotic pump technology (PMC4743634)
- Enteric-coated: bypasses gastric acid, releases silymarin in the small intestine where absorption is more favorable
Co-Formulation Options:
- Milk Thistle + Turmeric Curcumin (liver antioxidant support)
- Milk Thistle + NAC (glutathione precursor support)
- Milk Thistle + Artichoke + Dandelion (bile flow support)
- Milk Thistle + DHM (dihydromyricetin, hangover recovery positioning)
- Milk Thistle + B-Complex (metabolic support)
Tablet Appearance: Color (white, green, brown, custom), logo embossing, scoring lines for dose splitting
Packaging: HDPE bottles with induction seal, blister packs (Alu-Alu for maximum light/moisture protection), bulk packs
Labeling Claims Support: GMP-produced, non-GMO, gluten-free, vegan, allergen-free documentation available
Quality Control: USP-Compliant Testing
We test every batch against the standards set by the United States Pharmacopeia (USP) monograph for Milk Thistle Tablets:
Identity verification: HPLC fingerprint matching — confirming all six major flavonolignan peaks (silydianin, silychristin, silybin A, silybin B, isosilybin A, isosilybin B) with correct retention times and resolution factor R ≥ 1.0 between silybin A and silybin B.
Potency testing: Content must fall within 90-110% of labeled silymarin amount, calculated as the sum of all six flavonolignans expressed as silybin (C₂₅H₂₂O₁₀).
Dissolution testing: Per USP <2040> requirements for Milk Thistle Tablets — ensuring the silymarin dissolves at the required rate under standardized conditions.
Additional testing:
- Weight variation (USP <2091>)
- Microbial enumeration (total bacterial count ≤10⁴ cfu/g, molds/yeasts ≤10³ cfu/g, meets Salmonella/E. coli absence requirements)
- Residual solvents (USP <467>)
- Heavy metals (≤10 ppm)
- Pesticide residues
- Stability testing (accelerated and long-term)
This level of testing is why brands trust us with their milk thistle products. We don't just compress powder into tablets — we verify that every tablet meets pharmacopeial standards for identity, potency, and dissolution.
Market Context
The global milk thistle products market continues to grow, driven by increasing consumer awareness of liver health, rising demand for herbal supplements, and expanding applications in sports nutrition and hangover recovery categories.
Tablets represent an underserved opportunity. Most milk thistle products are sold as capsules or softgels. Brands that differentiate with high-quality, dissolution-verified tablets can capture consumers looking for:
- Higher potency per serving (fewer units per dose)
- Better value (lower cost per mg of silymarin)
- Longer shelf life and better stability
- Professional-grade quality (USP-compliant testing)
Frequently Asked Questions
Q: Why choose tablets over capsules for milk thistle?
For high-dose formulations (300mg+ silymarin per serving), tablets deliver the target dose in fewer units. Tablets also provide superior stability for oxidation-sensitive silymarin — the compressed matrix and film coating create a physical barrier against moisture and oxygen. Additionally, tablet compression costs 30-40% less per unit than capsule filling at scale, giving brands better margins. The trade-off is more complex formulation requirements — silymarin's poor solubility and heat sensitivity demand careful process control.
Q: How do you ensure each tablet contains the correct amount of silymarin?
We test every batch using HPLC (High-Performance Liquid Chromatography) per USP monograph requirements. We verify all six major flavonolignan peaks — silydianin, silychristin, silybin A, silybin B, isosilybin A, and isosilybin B — and calculate total silymarin content as the sum of all six expressed as silybin. Content must fall within 90-110% of label claim. We also verify silybin B/silybin A ratios (~1.58) as an authenticity fingerprint — deviations signal potential adulteration. Each tablet also undergoes dissolution testing per USP <2040>.
Q: What's the typical shelf life of milk thistle tablets?
With proper formulation (moisture-controlled granulation, film coating) and packaging (sealed, light-resistant containers), our milk thistle tablets maintain >95% silymarin content for 24-36 months. The key factors are moisture control (keeping granulation moisture at 2-4%), oxygen barrier (Alu-Alu blister or HDPE with induction seal), and light protection (opaque packaging or amber bottles). Accelerated stability testing at 40°C/75% RH for 6 months confirms long-term performance.
Q: Can you make enteric-coated milk thistle tablets?
Yes. Enteric coating is actually a smart strategy for milk thistle tablets, because silybin degrades significantly at gastric pH (pH 1.2, with >20% degradation within 2 hours). An enteric coating keeps the tablet intact through the stomach and releases silymarin in the small intestine (pH 6.8), where dissolution and absorption are more favorable. We offer standard enteric-coated tablets and can also develop sustained-release formulations with controlled release over 8-12 hours.
Q: What co-ingredients work well with milk thistle in tablet form?
The most effective combinations depend on the brand positioning:
- Liver antioxidant support: Milk Thistle + Turmeric Curcumin (500mg) + NAC (300mg)
- Hangover recovery: Milk Thistle + DHM (200mg) + B-Complex + Vitamin C
- Digestive health: Milk Thistle + Artichoke Extract (300mg) + Dandelion Root (500mg)
- Comprehensive detox: Milk Thistle + TUDCA (250mg) + NAC (600mg) + Alpha Lipoic Acid (200mg)
All co-ingredients must be compatible with the tablet compression process — we verify that no ingredient degrades under compression temperature and pressure, and that the combined formulation still meets dissolution requirements.
Q: What is the MOQ?
Our minimum order quantity for milk thistle tablets is 300,000 tablets. This applies to standard formulations with our existing tooling. Custom shapes, sizes, or enteric coatings may have higher minimums depending on setup requirements.
Q: How long does production take?
Sample development takes 7-10 working days. Bulk production takes 15-25 working days depending on order quantity and formulation complexity. Enteric-coated or sustained-release formulations may require an additional 5-7 working days for coating process and quality testing.
Ready to Start Your Milk Thistle Tablet Project?
Contact us today to discuss your milk thistle liver detox tablet formulation. Send us your target specifications — silymarin strength, tablet size, co-ingredients, and packaging preferences — and we'll provide a detailed quote within 48 hours.
Related articles:
- Custom Capsule Supplements Manufacturer
- Custom Herbal & Botanical Capsule Supplement Manufacturing
- Mushroom Supplement Capsules Contract Manufacturing
- Vitamin & Mineral Capsule Manufacturing
- Sports & Performance Capsule Manufacturing
- Metabolic, Detox & Weight Management Capsules
- skin care capsule
Related Products:
Get a Free Quote
If you need more information about our products, please feel free to contact us, we will provide you with professional service personnel, we will reply promptly after receiving the information.
FAQ
Q
Can you customize product formulations based on cross-border market demands?
A
Absolutely, we can tailor product formulations to meet local consumer preferences and regulatory requirements in your target markets.
Q
Can you provide multilingual labeling and instructions for cross-border products?
A
Certainly, we offer multilingual labeling and instructions to ensure accurate communication of product information in different countries' markets.
Q
What is the MOQ for cross-border business?
A
Our cross-border business MOQ is low, typically ranging from 1000 to 5000 units of products, and can be flexibly adjusted based on specific circumstances.
Q
Can you directly ship to overseas warehouses or facilitate split shipments?
A
We support direct delivery to overseas warehouses and can arrange split shipments according to your needs. We have well-established global logistics solutions.
Q
Do you support commonly used payment methods for cross-border markets?
A
Yes, we support widely used cross-border payment settlement methods such as PayPal, credit cards, and TT bank transfers.
Q
Can you provide import customs clearance documents for major countries?
A
Yes, we can provide customs registration information, inspection reports, and other customs clearance documents for different countries.
Q
Does your product packaging design comply with regulatory requirements in major countries?
A
Our product packaging design can be adjusted to meet the regulatory standards and requirements of different countries, ensuring compliance with local norms.
Q
Can you conduct small-scale production for cross-border testing?
A
Certainly,we welcome small-scale trial orders. We have dedicated small-scale production lines available for cross-border market testing,assisting you in evaluating market potential and feedback.